AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Use of AI algorithm for PCa detection is feasible, and AI-informed biopsies (AI-targeted and perilesional biopsy) improves csPCa detection in patients with indeterminate MRI lesions and in patients with low-risk MRI lesions and high-risk clinical features.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 40 lat lub więcej
- •Wykonane MRI prostaty w ciągu ostatnich 12 tygodni
- •Podwyższony poziom PSA we krwi (3.0 ng/ml lub wyżej dla pacjentów 40-75 lat, 4.0 ng/ml dla starszych)
- •Wyniki MRI pokazujące niepewne zmiany (PIRADS 3) lub niskie ryzyko zmian (PIRADS 1-2) z dodatkowymi czynnikami ryzyka
- •Dobry ogólny stan zdrowia, zdolny do zniesienia zabiegu
✗ Disqualifies
- •Poniżej 18 lat
- •Wysokie ryzyko zmian w MRI (PIRADS 4-5)
- •Już potwierdzony nowotwór złośliwy prostaty
- •Alergia na środki kontrastowe
- •Niezdolność do poddania się MRI lub biopsji z powodów medycznych
- •Warunki uniemożliwiające wykonanie MRI (np. metalowe implanty, nadmierny gaz w odbytnicę)
Simplified criteria — AI translation
Trial details
- Minimum age
- 40 Years
- Last updated (source)
- August 19, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (1)
University of Arkansas for Medical Sciences
Little Rock, United States
Trial contact
Aaron Holley
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/20/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.